What is LOPJLB’s current signal on PRTG?

LOPJLB’s latest quantitative signal on Portage Biotech Inc. (PRTG) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is PRTG in?

Portage Biotech Inc. (PRTG) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Portage Biotech Inc. (PRTG) do?

Portage Biotech Inc., operating through its various subsidiaries, focuses on the discovery and advancement of novel pharmaceutical and biotechnological products. The company's extensive pipeline includes several key therapeutic candidates and platforms. Among these are IMM60, an activator for iNKT cells; IMM65, a specialized PLGA-nanoparticle integrated with a NY-ESO-1 peptide vaccine; and INT2…

Where is Portage Biotech Inc. based / listed?

Portage Biotech Inc. is based in VG, listed on NASDAQ.

Portage Biotech Inc. (PRTG)

Healthcare · Biotechnology · NASDAQ · VG

$5.53-4.16%Close

SELLCRISIS · day 25

[SCORES & PROFILE]

FUND: 0
VALUE: 5
GROWTH: 15
GARP: 5
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-

REV YoY-

ROE-

EPS YoY-

ROA-197.8%

GROSS

100

-23810

NET

-39821

[VALUATION]

P/E TTM-1.63

P/E FWD-

SECTOR PE22.57

INDUSTRY PE17.06

P/B8.71

P/FCF-

EV/EBITDA-1.81

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E1.91

ALTMAN Z-

CURR RATIO0.31

ND/EBITDA-

BETA0.64

Portage Biotech Inc. (PRTG)

Key stats

Sector peers

Prediction markets

FUNDAMENTALS

Company news